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Abstract. 
 
Membrane receptors are internalized either 
constitutively or upon ligand engagement. Whereas 
there is evidence for differential regulation of the two 
processes, little is known about the molecular machin-
ery involved. Previous studies have shown that an un-
identiﬁed kinase substrate is required for endocytosis 
of the epidermal growth factor receptor (EGFR), the 
prototypical ligand-inducible receptor, but not of the 
transferrin receptor (TfR), the prototypical constitu-
tively internalized receptor. Eps15, an endocytic pro-
tein that is tyrosine phosphorylated by EGFR, is a can-
didate for such a function. Here, we show that tyrosine 
phosphorylation of Eps15 is necessary for internaliza-
tion of the EGFR, but not of the TfR. We mapped Tyr 
850 as the major in vivo tyrosine phosphorylation site 
of Eps15. A phosphorylation-negative mutant of Eps15 
acted as a dominant negative on the internalization of 
the EGFR, but not of the TfR. A phosphopeptide, cor-
responding to the phosphorylated sequence of Eps15, 
inhibited EGFR endocytosis, suggesting that phospho-
tyrosine in Eps15 serves as a docking site for a phos-
photyrosine binding protein. Thus, tyrosine phos-
phorylation of Eps15 represents the ﬁrst molecular 
determinant, other than those contained in the recep-
tors themselves, which is involved in the differential 
regulation of constitutive vs. regulated endocytosis.
Key words: Eps15 • phosphotyrosine • endocytosis • 
epidermal growth factor receptor • transferrin receptor
 
Introduction
 
Receptor-mediated endocytosis constitutes an important
mechanism through which cells internalize membrane re-
ceptors, thereby regulating the uptake of nutrients or the
permanence of signaling receptors at the plasma mem-
brane. Two major classes of receptors are subjected to this
process, constitutively internalized and ligand-inducible
receptors, whose prototypes are the transferrin (Tf)
 
1
 
 re-
ceptor (TfR) and the EGF receptor (EGFR), respectively.
Whereas the intracellular routing and the metabolic des-
tiny of the two types of receptors are distinct (Dickson et
al., 1983; Gorman and Poretz, 1987; Jackle et al., 1991),
the initial phases of endocytosis appear to proceed accord-
ing to a common scheme. Specialized surface structures,
called coated pits, function in both cases as recruitment
and concentration centers for internalizing receptors, and
then progressively invaginate until they are pinched off
from the plasma membrane. Three major components
constitute the hardware of a coated pit: clathrin, the AP2
complex, and dynamin. Clathrin provides the organizing
framework of the pit, AP2 drives clathrin assembly and in-
teracts with endocytic signals present on the receptors, and
dynamin is required for fission of the vesicle from the
plasma membrane (see Robinson, 1994; Seaman et al.,
1996; Pishvaee and Payne, 1998; Kirchhausen, 1999; Marsh
and McMahon, 1999).
Despite structural and molecular similarities, coated
pits internalizing constitutive or ligand-inducible receptors
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must differ, as indicated by findings that endocytosis is a
saturable process in which EGFRs compete with them-
selves, but not with TfRs (Hanover et al., 1984; Wiley,
1988; Warren et al., 1997). It is now clear that one major
difference resides in the receptors themselves. Consti-
tutively internalized receptors continuously expose en-
docytic codes, which are responsible for interaction with
the recruiting complex, AP2 (Nesterov et al., 1999).
Ligand-induced receptors and, in particular, receptor
tyrosine kinases (RTKs), possess cryptic codes that are
unmasked by conformational changes after ligand en-
gagement, receptor activation, and autophosphorylation
(Nesterov et al., 1995a,b). Thus, for receptors such as the
EGFR, tyrosine kinase activity is required for internaliza-
tion. Studies by Lamaze and Schmid (1995) demonstrated
that a kinase substrate, other than the autophosphorylat-
ing receptor itself, is required for the efficient recruitment
of EGFRs, but not of TfRs, into coated pits. Such a sub-
strate might coincide with one of the several accessory
proteins that are found in coated pits at substoichiometric
ratios and are thought to constitute the regulatory soft-
ware of the endocytic process (Pishvaee and Payne, 1998;
Marsh and McMahon, 1999).
One such protein, Eps15, was originally identified as a
substrate of the EGFR kinase (Fazioli et al., 1993) and
subsequently implicated in endocytosis (Carbone et al.,
1997; Benmerah et al., 1998, 1999). Eps15 is endowed with
multiple binding activities. Through its COOH-terminal
portion, it binds to the 
 
a
 
 subunit of the AP2 complex. In
addition, the presence of three copies of the EH protein–
protein interaction domain allows Eps15 to establish mul-
tiple interactions with endocytic/sorting proteins, includ-
ing Epsin (Salcini et al., 1997; Chen et al., 1998). Eps15 is
recruited to the plasma membrane upon EGFR activation
(Torrisi et al., 1999) and localizes to coated pits (Tebar et
al., 1996). In this study, we demonstrate that tyrosine
phosphorylation of Eps15 is required for EGFR, but not
for TfR, internalization. Thus, tyrosine phosphorylation of
Eps15 constitutes the first example of a molecular event,
affecting the endocytic machinery, which is involved in the
differential regulation of ligand-induced and constitutive
internalization.
 
Materials and Methods
 
Production of Recombinant Proteins and In Vitro 
Kinase Assays
 
GST fusion proteins were obtained by recombinant PCR using the murine
Eps15 cDNA as a template. The EGFR kinase domain was purchased
from Stratagene and in vitro kinase assays were performed according to
the manufacturer’s instructions, using 5 
 
m
 
g of GST-fusion proteins as sub-
strates.
 
Mammalian Expression Vectors
 
An HA-tagged Eps15 (HA-Eps15) under the transcriptional control of
the CMV promoter was generated by subcloning a fragment of the mouse
Eps15 cDNA, obtained by PCR and encompassing positions 2–897, in the
pcDNA-1-HA vector (a generous gift of S. Gutkind, National Institutes of
Health, Bethesda, MD). Individual Tyr
 
®
 
Phe mutations were generated
by recombinant PCR, followed by swapping of the appropriate fragments
in the HA-Eps15 vector, to yield the HA-Y850F vector and the other vec-
tors harboring mutations at Tyr 19, 22, 23, and 525. Wild-type Eps15 and
the Y850F mutant were also cloned in the pEGFP vector (Clontech), to
 
generate the GFP-fusion proteins GFP-Eps15 and GFP-Y850F. Details of
the engineering strategies and sequences of the oligonucleotides used are
available upon request. All fragments obtained by PCR were sequence-
verified.
 
Transfection, Microinjection, and Biochemical Assays
 
B82L (a kind gift of G.N. Gill, University of California, San Diego, School
of Medicine, La Jolla, CA) and Cos-7 cells were transfected with lipo-
fectamine (GIBCO BRL) or by DEAE-dextran methods, respectively.
For microinjection experiments CV-1 cells were processed as described
previously (Carbone et al., 1997). Peptides were microinjected in the cyto-
plasm of the cells at a concentration of 800 
 
m
 
M.
Immunoprecipitation, immunoblotting and coimmunoprecipitations
were performed as previously described (Salcini et al., 1997).
mAbs used were: a commercial antiphosphotyrosine (Upstate Bio-
tech), an anti-
 
a
 
-adaptin (Sigma-Aldrich), the anti-EGFR mAb-1 (Onco-
gene Science), and the anti-HA 12CAS. A polyclonal anti-Numb serum
(Salcini et al., 1997) was also used.
EGF and transferrin internalization assays were performed as previ-
ously described (Carbone et al., 1997). In brief, 24 h after transfection,
cells were serum-starved for 16 h and then incubated for 1 h at 4
 
8
 
C with
rhodamine-EGF (R-EGF, 500 ng/ml). Cells were then shifted to 37
 
8
 
C for
10 min to allow internalization. For transferrin internalization, cells were
incubated in serum-free medium for 3 h and then with R-Tf (50 
 
m
 
g/ml) for
30 min at 37
 
8
 
C.
 
Immunofluorescence and Confocal Microscopy
 
Cells transfected with GFP-Eps15 or GFP-Y850F were fixed with 4%
formaldehyde, followed by permeabilization with 0.1% Triton X-100. Af-
ter blocking with 10% normal goat serum, cells were stained with anti-
EGFR or mounted directly for confocal analysis. Cells transfected with
HA-Eps15 or HA-Y850F cDNAs were similarly processed and stained
with anti-HA antibodies. Bound antibodies were visualized with anti-
mouse IgG-Cy3 (EGFR) or anti-mouse IgG-FITC (HA). Nuclear coun-
terstaining was performed with DAPI (Sigma-Aldrich). Coverslips were
analyzed with a Zeiss Axiophot epifluorescence microscope or a BioRad
MRC 1024 confocal microscope. Images were processed using the Adobe
PhotoShop software.
 
Electron Microscopy
 
For immunoelectron microscopy, 10% gelatin-embedded, 2.3 M sucrose-
infused blocks of aldehyde-fixed growing B82L cells, transfected with ei-
ther HA-Eps15 or HA-Y850F cDNAs, were frozen in liquid nitrogen. Ul-
tra thin cryosections were obtained with a Reichert-Jung Ultracut E with
FC4E cryoattachment and collected on copper formvar carbon-coated
grids. Double immunogold localizations on ultrathin cryosections were
performed as previously described (Schiaffino et al., 1999). In particular,
sections were immunostained with mouse monoclonal anti-hEGFR (AB-5,
Oncogene Science) or goat anti-hTfR (CD71 K-20, Santa Cruz Biotech-
nology, Inc.) antibodies, followed by appropriate rabbit anti–mouse or
rabbit anti–goat bridging antibodies and 10-nm protein A–gold. After in-
cubation with 1% glutaraldehyde in 0.1 M sodium phosphate buffer, to
quench free antibody protein A binding sites, the sections were chal-
lenged with rabbit anti-HA antibody (Santa Cruz Biotechnology, Inc.),
followed by 15-nm protein A–gold. Control sections were incubated with
an unrelated antibody, or without primary antibodies. To determine
quenching efficiency, sections incubated with anti-EGFR or anti-TfR anti-
bodies were quenched with 1% glutaraldehyde, in 0.1 M sodium phos-
phate buffer, and challenged with protein A. In all control sections, low
levels of labeling were detected (not shown). Sections were examined with
Zeiss EM 902 or EM10C electron microscopes.
 
Results
 
Tyrosine 850 Is the Major Tyrosine Phosphorylation 
Site in Eps15 
 
Previously, we have demonstrated that Eps15 can be phos-
phorylated in vitro by the EGFR (Fazioli et al., 1993).
Thus, as an initial approach towards mapping of the ty-
rosine phosphorylation site of Eps15, we employed a puri- 
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Figure 1. Tyrosine 850 is the major tyrosine phosphorylation site
in Eps15. A, Schematic representation of Eps15 and of its frag-
ments (numbered 1–6). The positions of the Tyr residues (Y),
and the domains of Eps15, are indicated. B, Recombinant GST
fragments of Eps15 were incubated with purified EGF-R kinase
and g[32P]ATP. Eps15 fragments are as in A: 1, aa 9–216; 2, aa
122–216; 3, aa 218–315; 4, aa 321–521; 5, aa 501–622; and 6, aa
751–874. Asterisks indicate the positions of the GST-Eps15 frag-
ments, as determined by Coomassie blue staining. C, Cos-7 cells,
transiently transfected (Tfx) with either HA-Eps15 or HA-
Y850F were stimulated with EGF (100 ng/ml) for the indicated
times. Total cellular proteins (5 mg) were immunoprecipitated
with the anti-HA mAb, followed by immunoblotting with anti-
pY (WB a-pY, 4/5 of the sample) or anti-HA (WB a-HA, 1/5 of
the sample) mAbs.
 
Figure 2.
 
Mutation of Tyr850 of Eps15 does not alter the binding
and routing properties of Eps15, but it interferes with EGFR
trafficking. A, Cos-7 cells were transiently transfected (Tfx) with
either HA-Eps15 or HA-Y850F and treated with EGF (100 ng/
ml for 10 min, 
 
1
 
 lanes) or mock-treated (
 
2
 
 lanes). Total cellular
proteins (2 mg) were immunoprecipitated with the anti-HA
mAb, followed by immunoblotting with anti-pY (WB 
 
a
 
-pY) or
anti-
 
a
 
-adaptin (WB 
 
a
 
-AP2) mAbs. An aliquot (1/5) of the immu-
noprecipitates was immunoblotted with the anti-HA mAb (WB
 
a
 
-HA) to check for equal loading. B, Cos-7 cells were transiently
transfected with either HA-Eps15 or HA-Y850F or the corre-
sponding empty vector (Ctr) and treated with EGF 100 ng/ml for
10 min, (
 
1
 
 lanes) or mock-treated (
 
2
 
 lanes). Total cellular pro-
teins (4 mg) were immunoprecipitated (ip) with anti-Numb se-
rum or with control serum (Ctr), followed by immunoblotting
with anti-HA (top) or anti-Numb (bottom) mAbs. C–F, B82L
cells were transiently transfected with either GFP-Eps15 (C and
D) or GFP-Y850F (E and F). After serum starvation, cells were
either mock-treated (C and E) or treated with EGF (100 ng/ml)
at 4
 
8
 
C for 1 h (D and F) and analyzed by confocal microscopy. A
representative horizontal section is shown. G and H, Cryosec-
tions of B82L cells transfected with either HA-Eps15 (G) or HA-
Y850F (H) were labeled with anti-HA and anti-EGFR mAbs, as
described in Materials and Methods. HA, 15-nm gold; EGFR, 10-
nm gold. Bars: (G) 0.12 
 
m
 
m; (H) 0.14 
 
m
 
m. Morphometric data: 40
labeled coated pits were counted in each of the two experimental
conditions. Data express the number of pits where EGFR colo-
calize with HA-Eps15 or HA-Y850F (HA
 
1
 
EGFR) and where
only HA or EGFR staining is detectable. 
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fied EGFR kinase to phosphorylate recombinantly ex-
pressed and purified fragments of Eps15 (Fig. 1 A). An
Eps15 COOH-terminal fragment, encompassing positions
751–874 and containing Tyr850, was efficiently phosphory-
lated, whereas other segments of the protein were poor
substrates for the EGFR kinase in vitro (Fig. 1 B).
We engineered a mutant in which Tyr850 was mutated
to Phe, in the context of an HA-tagged full-length Eps15
(HA-Y850F). As controls, we also engineered mutants in
which Tyr 19, 22, 23, and 525 were individually mu-
tagenized to Phe, and an HA-tagged wild-type Eps15
(HA-Eps15). When the HA-Y850F was transfected in
Cos-7 cells, little if any tyrosine phosphorylation could be
detected upon EGF stimulation from one minute to three
Figure 3. The Y850F tyrosine
phosphorylation mutant of
Eps15 inhibits endocytosis of
the EGFR, but not of the
TfR. A, B82L cells were tran-
siently transfected with either
GFP-Eps15 or GFP-Y850F.
After serum starvation cells
were treated with EGF (100
ng/ml) for 1 h at 48C, fol-
lowed by shift at 378C for 10
min, to allow internalization.
Cells were stained with the
anti-EGFR mAb. Trans-
fected cells, identified by
GFP epifluorescence, are
marked with asterisks. Nu-
clei are counterstained in
blue with DAPI. B, Surface
EGFR immunostaining on
HA-Eps15 or HA-Y850F
transfected B82L cells.
EGFR (10-nm gold particles)
was revealed by preembed-
ding immunogold staining of
PFA fixed cells. 5-nm gold la-
beled BSA was used as
tracer. Micrographs show two
examples of portions of cell
profiles of HA-Eps15 (top)
and HA-Y850F (bottom)
transfected cells. Arrows
point to 10-nm gold particles.
The number of 10-nm gold
particles per cell profile was
counted (20 cell profiles per
experimental condition), and
yielded the following results
(number of gold particles per
cell profile). HA-Eps15 trans-
fected B82L cells, 44.14 parti-
cles, Bar, 0.19 mm. HA-
Y850F transfected B82L
cells, 121.71 particles. Bar,
0.16  mm. C, B82L cells were
transfected with either HA-
Y850F (left) or HA-Eps15
(right), and subsequently in-
cubated with R-EGF (500 ng/
ml) or R-Tf (50 mg/ml) as de-
scribed in Materials and
Methods. Transfected cells
were identified with the anti-
HA mAb and marked with
asterisks. Nuclei are counter-
stained in blue with DAPI. 
Confalonieri et al. 
 
Eps15 Phosphorylation in Endocytosis
 
909
 
hours, whereas the HA-Eps15 was efficiently phosphory-
lated (Fig. 1 C). Tyrosine phosphorylation of the other
Tyr
 
®
 
Phe mutants was indistinguishable from that of wild-
type Eps15 (not shown). We concluded that Tyr 850 is the
major tyrosine phosphorylation site in Eps15.
 
Lack of Phosphorylation Does Not Alter the Binding 
and Routing Properties of Eps15 
 
Eps15 is endowed with multiple binding properties (re-
viewed in Santolini et al., 1999). We tested whether inter-
actions established by Eps15 were affected by its phos-
phorylation status. The Y850F mutant retained intact
abilities to bind to AP2 (Fig. 2 A) and to Numb, an EH-
binding protein (Fig. 2 B), indicating that the mutation did
not affect in a major way the conformation of the protein.
We have previously shown that, upon EGF stimulation,
a pool of Eps15 is recruited to the plasma membrane (Tor-
risi et al., 1999). We investigated whether tyrosine phos-
phorylation of Eps15 is responsible for this phenomenon.
B82L cells, transfected with either GFP-Y850F or GFP-
Eps15, were stimulated with EGF at 4
 
8
 
C, to prevent recep-
tor internalization, and analyzed by confocal microscopy.
Both wild-type and mutant Eps15 were similarly translo-
cated to the plasma membrane (Fig. 2, C–F). EM analysis
revealed that both HA-Eps15 and HA-Y850F were prop-
erly targeted to coated pits containing either activated
EGFR (Fig. 2, G and H) or TfR (not shown).
 
 
 
Thus, ty-
rosine phosphorylation of Eps15 is not required for its
membrane translocation after EGF treatment or for its
targeting to coated pits.
 
 
 
However, when cells loaded with
EGF at 4
 
8
 
C were shifted to 37
 
8
 
C, to allow internalization,
reduced internalization of the EGFR was visible in GFP-
Y850F, with respect to GFP-Eps15 transfectants (Fig. 3
A). This finding was further corroborated by EM experi-
ments that showed a clear accumulation on the plasma
membrane of the EGFR in HA-Y850F transfectants,
when compared with HA-Eps15 transfectants (Fig. 3 B).
This suggested that the Y850F mutant could function as a
dominant negative on the internalization process.
 
Tyrosine Phosphorylation of Eps15 Is Required for 
Endocytosis of the EGFR, but Not of the TfR 
 
To test the relevance of tyrosine phosphorylation of Eps15
in the process of receptor-mediated endocytosis, we trans-
fected the HA-Y850F mutant and the control HA-Eps15
in B82L cells, which overexpress the EGFR, and mea-
sured the uptake of fluorochrome-conjugated EGF or Tf.
B82L-HA-Y850F displayed an almost complete inhibition
(
 
.
 
80% of the expressing cells) of EGF uptake, whereas Tf
internalization was unaffected (Fig. 3 C). Conversely,
B82L-HA-Eps15 cells did not show any perturbation of
the internalization of either EGF or Tf (Fig. 3 C). Similar
results were obtained in Cos-7 cells (not shown).
EM analysis of the distribution of the EGFR in en-
docytic compartments, in HA-Y850F vs. HA-Eps15 trans-
fectants, further confirmed the block in EGFR internaliza-
tion and provided insight as to the mechanisms involved.
In both transfectants, EGFRs were comparably recruited
to coated pits, once cells loaded with EGF at 4
 
8
 
C were al-
lowed to undergo endocytosis by temperature shift at 37
 
8
 
C
for two minutes (Fig. 4 A). However, whereas EGFRs in
HA-Eps15 transfectants were able to progress to the intra-
cellular stations of the endocytic route (coated vesicles
and endosomes), they were severely impaired in doing so
in HA-Y850F transfectants (Fig. 4, B and C). Thus, it ap-
pears as if the block in EGFR endocytosis induced by the
HA-Y850F mutant is at a level subsequent to the recruit-
ment of the receptor in the forming pit.
 
Tyrosine Phosphorylation of Eps15 Creates a Docking 
Site for a pY-binding Protein 
 
Two models can be envisioned to account for the role of
tyrosine phosphorylation of Eps15. In one model, phos-
phorylation might induce a conformational change re-
sponsible for the transition of Eps15 from an inactive to an
active state. In the other, the pY residue might serve as a
docking site for a pY-binding protein, which in turn might
be responsible for some specific function in the endocyto-
sis of the EGFR. If the latter model were true, then a
Figure 4. EGFRs are effi-
ciently recruited into coated
pits, but are not further traf-
ficked in cells expressing
HA-Y850F. Morphometric
analysis of EGFR localiza-
tion, as detected by immu-
noelectron microscopy in
HA-Eps15 vs. HA-Y850F
transfected cells. 24 h after
transfection, B82L cells were
serum-starved for 16 h (SF),
loaded with EGF (100 ng/ml)
for 1 h at 48C (48C 1 EGF),
and were then shifted at 378C
for 2 min (378C  1  EGF 2’)
and 10 min (378C 1 EGF 10’)
to allow endocytosis. Staining
and fixing were as in Fig. 3 B. Numbers of gold particles counted are the mean of 10 cell profiles per experimental condition in the three
compartments: A, coated pits; B, coated vesicles; C, endosomes. 
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phosphopeptide corresponding to the phosphorylated se-
quence of Eps15 might titer out in vivo, the hypothetical
pY-binding protein, resulting in inhibition of EGFR en-
docytosis. A peptide, ANFSApYPSEED, was synthesized,
which corresponds to position 845–855 of mouse Eps15,
and was microinjected into CV-1 cells. This peptide led to
a complete block in endocytosis of EGFR in 
 
.
 
80% of the
microinjected cells, leaving Tf endocytosis unaltered (Fig.
5). Control peptides, in which the pY was replaced by a
Tyr or a Phe (Fig. 5, ANFSAYPSEED and ANFSAFP-
SEED), did not interfere with either EGF or Tf internal-
ization. We concluded that tyrosine phosphorylation of
Eps15 most likely creates a docking site for an as yet un-
identified pY-binding protein.
 
Discussion
 
In this study, we establish tyrosine phosphorylation of
Eps15 as the first known molecular determinant, other
than those contained in the receptors themselves, which is
required in the differential regulation of endocytosis of
ligand-inducible vs. cargo receptors. When viewed in the
context of existing knowledge, our findings reveal a com-
plex picture. Previous studies suggested that Eps15 has a
general role in receptor-mediated endocytosis. Indeed, ex-
pression of dominant negative mutants of Eps15 or micro-
injection of neutralizing antibodies inhibited endocytosis
of both EGFR and TfR (Carbone et al., 1997; Benmerah
et al., 1998). Results obtained with dominant negative mu-
tants should be evaluated with caution, in that the effects
might be indirect and due to titering out in vivo of AP2, to
which Eps15 is known to bind stoichiometrically (Ben-
merah et al., 1995; Tebar et al., 1996; Iannolo et al., 1997).
However, results obtained with neutralizing antibodies are
not prone to the same interpretative caveat. Anti-Eps15
antibodies could only inhibit AP2 molecules stably bound
to Eps15. However, there is a vast excess of AP2 over
Eps15 in the cell, since most AP2 is not bound to Eps15,
whereas most, if not all, Eps15 is complexed with AP2
(Tebar et al., 1996; Cupers et al., 1998). Thus, the great
majority of the AP2 pool should be insensitive to neutral-
ization with anti-Eps15 antibodies. Therefore, it seems
reasonable to assume that Eps15 has a general function in
endocytosis.
Our results, however, show that tyrosine phosphoryla-
tion of Eps15 is required exclusively in the process of
ligand-induced receptor internalization. Two hypotheses
allow to reconcile this observation with previous findings.
It is possible that Eps15 is endowed with a dual function:
one connected with the protein itself that is of general rel-
evance to endocytosis, and one connected with its tyrosine
phosphorylation that is specific for the internalization of
RTKs. Alternatively, there may be just one function that is
optimized by tyrosine phosphorylation when there is need
for efficient removal of receptors from the surface, as it
might be required after ligand stimulation.
What is the role of tyrosine phosphorylation of Eps15?
Our results allow us to exclude that this posttranslational
modification is required for any of the known protein–pro-
tein interactions of Eps15. Furthermore, tyrosine phos-
Figure 5. A phosphopeptide corresponding to the phosphorylated sequence of Eps15 inhibits endocytosis of the EGFR, but not of the
TfR. CV-1 cells were microinjected with the peptides indicated at the bottom, together with mouse IgG, as a marker, and then incu-
bated with rhodamine-EGF (A–C) or rhodamine-Tf (D–F). Internalizing ligands are visible in red. Injected cells were identified using
an FITC-conjugated goat anti-mouse IgG (not shown) and are marked by asterisks. 
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phorylation does not seem to be required for proper relo-
calization of Eps15 to the plasma membrane, or for its
targeting to coated pits. Finally, it appears that phosphory-
lation-impaired mutants of Eps15 do not interfere with
EGFR recruitment to pits, but rather with subsequent
phases of the internalization process. Thus, the point of ac-
tion of phospho-Eps15 might be at the level of vesicula-
tion. Such a function could be linked to the scaffolding
properties of Eps15, and possibly to the function of dy-
namin, as indirectly suggested by the localization of Eps15
at the rim of coated pits (Tebar et al., 1996); also, by the
site of dynamin localization and by our findings of genetic
interaction between the 
 
C
 
.
 
 elegans
 
 homologues of dy-
namin and Eps15 (Salcini, A.E., P.P. Di Fiore, and P. Baz-
zicalupo, unpublished results).
While the molecular mechanisms of action of phospho-
Eps15 remain to be clarified, an interesting avenue of in-
vestigation is opened by our findings that tyrosine phos-
phorylation of Eps15 might create a docking site for an as
yet unidentified pY-binding protein. Many SH2- or PTB/
PID-containing proteins are recruited to the EGFR after
receptor activation, some of which have also been impli-
cated in endocytosis (Okabayashi et al., 1996; Wang and
Moran, 1996; Wang et al., 1996; Sanchez et al., 1998). The
identification of binding partners for phospho-Eps15 might
help to elucidate the exact molecular mechanism(s) through
which Eps15 regulates the endocytic process.
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